Diluted EPS came in at $-0.41 (+90.3% YoY).
Trailing eight quarters through Q1 2025
Common questions about Phio Pharmaceuticals Corp.'s Q1 2025 earnings report.
Phio Pharmaceuticals Corp. (PHIO) reported Q1 2025 earnings on May 15, 2025 before market open.
Phio Pharmaceuticals Corp. reported diluted EPS of $-0.41 for Q1 2025.
Compared to the same quarter a year prior, diluted EPS grew 90.3% from $-4.23.
You can read the 10-K periodic report (0001683168-25-002134) directly on SEC EDGAR. The filing index links above go to sec.gov.